Sunshine Biopharma Inc announces that its breast cancer drug candidate, Adva-27a, also destroys pancreatic cancer cells

Source :: Chemical Business Newsbase. June 4, 2013
Publication Year :: 2013
Abstract: Sunshine Biopharma Inc has completed a new IND-Enabling study in which Adva-27a, the company's flagship oncology drug candidate for breast cancer was found to be effective at killing Pancreatic Cancer [...]

Subjects :: Biological products industry
Antineoplastic agents
Cancer -- Care and treatment
Cancer cells
Breast cancer -- Drug therapy
Pancreatic cancer -- Drug therapy
Antimitotic agents
Business
Chemicals, plastics and rubber industries

Tools